1. Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes. (April 2014) Authors: Baker, D J; Wilkinson, G P; Atkinson, A M; Jones, H B; Coghlan, M; Charles, A D; Leighton, B Journal: British journal of pharmacology Issue: Volume 171:Number 7(2014:Apr.) Page Start: 1642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NP-018 Building capacity within a Hepatitis C treatment model. The validation process for a Hepatitis C pre-treatment pharmacist assessment complex intervention toolkit. (14th March 2021) Authors: Coghlan, M; O'Leary, A; Melanophy, G; Norris, S; Bergin, C Journal: European journal of hospital pharmacy Issue: Volume 28(2021)Supplement 1 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗